These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25604607)

  • 1. Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease.
    Rysz J; Gluba-Brzózka A; Mikhailidis DP; Banach M
    Expert Opin Investig Drugs; 2015 May; 24(5):603-10. PubMed ID: 25604607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic utilities of fibroblast growth factor 19.
    Wu X; Li Y
    Expert Opin Ther Targets; 2011 Nov; 15(11):1307-16. PubMed ID: 21961833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target.
    Liu WY; Xie DM; Zhu GQ; Huang GQ; Lin YQ; Wang LR; Shi KQ; Hu B; Braddock M; Chen YP; Zheng MH
    Expert Opin Ther Targets; 2015 May; 19(5):675-85. PubMed ID: 25547779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview of FGF19 and FGF21: The Therapeutic Role in the Treatment of the Metabolic Disorders and Obesity.
    Babaknejad N; Nayeri H; Hemmati R; Bahrami S; Esmaillzadeh A
    Horm Metab Res; 2018 Jun; 50(6):441-452. PubMed ID: 29883971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fibroblast growth factor 19 in the control of glucose homeostasis.
    Schaap FG
    Curr Opin Clin Nutr Metab Care; 2012 Jul; 15(4):386-91. PubMed ID: 22617565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mini-review: endocrine actions of fibroblast growth factor 19.
    Jones S
    Mol Pharm; 2008; 5(1):42-8. PubMed ID: 18179175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases.
    Zhang F; Yu L; Lin X; Cheng P; He L; Li X; Lu X; Tan Y; Yang H; Cai L; Zhang C
    Mol Endocrinol; 2015 Oct; 29(10):1400-13. PubMed ID: 26308386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FGF metabolic axis.
    Li X
    Front Med; 2019 Oct; 13(5):511-530. PubMed ID: 31495905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities.
    Wu X; Li Y
    Adv Exp Med Biol; 2012; 728():195-213. PubMed ID: 22396171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Saga of Endocrine FGFs.
    Phan P; Saikia BB; Sonnaila S; Agrawal S; Alraawi Z; Kumar TKS; Iyer S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFs and metabolism.
    Kharitonenkov A
    Curr Opin Pharmacol; 2009 Dec; 9(6):805-10. PubMed ID: 19683963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of FGF19 in liver metabolism.
    Kir S; Kliewer SA; Mangelsdorf DJ
    Cold Spring Harb Symp Quant Biol; 2011; 76():139-44. PubMed ID: 21813638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone-like fibroblast growth factors and metabolic regulation.
    Long YC; Kharitonenkov A
    Biochim Biophys Acta; 2011 Jul; 1812(7):791-5. PubMed ID: 21504790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes.
    Donate-Correa J; Martín-Núñez E; Delgado NP; de Fuentes MM; Arduan AO; Mora-Fernández C; Navarro González JF
    Cytokine Growth Factor Rev; 2016 Apr; 28():71-7. PubMed ID: 26706229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives.
    Somm E; Jornayvaz FR
    Endocr Rev; 2018 Dec; 39(6):960-989. PubMed ID: 30124818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.
    Angelin B; Larsson TE; Rudling M
    Cell Metab; 2012 Dec; 16(6):693-705. PubMed ID: 23217254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations.
    Mellor HR
    Liver Int; 2014 Jul; 34(6):e1-9. PubMed ID: 24393342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis.
    Zangerolamo L; Carvalho M; Velloso LA; Barbosa HCL
    Eur J Pharmacol; 2024 Jan; 963():176248. PubMed ID: 38056616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.
    Zweers SJ; Booij KA; Komuta M; Roskams T; Gouma DJ; Jansen PL; Schaap FG
    Hepatology; 2012 Feb; 55(2):575-83. PubMed ID: 21953282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity.
    Tomlinson E; Fu L; John L; Hultgren B; Huang X; Renz M; Stephan JP; Tsai SP; Powell-Braxton L; French D; Stewart TA
    Endocrinology; 2002 May; 143(5):1741-7. PubMed ID: 11956156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.